Saurborn Emily, Roth Danielle, Cook Shane
Dermatology, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
Cureus. 2025 Jan 2;17(1):e76780. doi: 10.7759/cureus.76780. eCollection 2025 Jan.
Angioedema involves fluid accumulation into the interstitial spaces of the dermis, subcutaneous tissue, and mucosal surfaces. While usually benign and self-limited, angioedema can lead to laryngeal edema, a life-threatening condition. The most common causes are histamine-mediated allergic reactions. However, angioedema can also be mediated by bradykinin. Bradykinin-mediated angioedema can occur in the setting of hereditary deficiency of C1q esterase and after exposure to several medications. Drug-induced angioedema is most commonly a secondary complication of non-steroidal anti-inflammatory drug (NSAID) or sulfa drug use. All providers must be aware of the potential side effects of the medications they use or prescribe. We present a case of angioedema resulting from the use of technetium-99m sestamibi tracer injection during an adenosine nuclear stress test.
血管性水肿涉及液体在真皮、皮下组织和黏膜表面的间质间隙中积聚。虽然血管性水肿通常是良性且自限性的,但它可导致喉水肿,这是一种危及生命的状况。最常见的病因是组胺介导的过敏反应。然而,血管性水肿也可由缓激肽介导。缓激肽介导的血管性水肿可发生在C1q酯酶遗传性缺乏的情况下以及接触多种药物之后。药物性血管性水肿最常见的是使用非甾体抗炎药(NSAID)或磺胺类药物后的继发性并发症。所有医疗服务提供者都必须了解他们使用或开具的药物的潜在副作用。我们报告一例在腺苷核素应激试验期间因注射锝-99m 司他美比示踪剂而导致血管性水肿的病例。